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The aim of this study was to determine factors associated with regular use of inhaled corticosteroids (ICS) by 
asthmatic patients in primary care practices. A cross-sectional survey was carried out over 12 family practices in the 
Philadelphia greater Metropolitan area. A total of 394 patients aged 1849 years, who received medical care for 
asthma from their primary care physician and had been prescribed ICS between 1 January 1995 and 31 December 
1996, were included. 
The study measured self-reported demographics, experience with asthma, use of and attitudes about ICS, and 
health beliefs in six domains. 
Only 38% of patients reported using ICS at least twice a day almost every day. The most frequently cited reasons 
for inconsistent or non-use of ICS were related to a belief that ICS were unnecessary during asymptomatic periods 
and to a general concern about side-effects. By logistic regression, factors associated with regular use of ICS were 
two patient health beliefs, namely the health belief of ‘Active’ participation in clinical decision-making with their 
physician (OR=4.6, 95% CI 2.8, 7.5) and the health belief that asthma was a ‘Serious’ health problem (OR=2.3, 
95% CI 1.4, 3.7), and hospitalization for asthma within the previous 12 months (OR=2.3, 95% CI 1.6, 4.6). 
Patients were more likely to report regular use of ICS if they saw themselves as active participants in their 
treatment planning and conceptualized asthma as a potentially serious illness. These results support the themes of 
patient education and shared decision-making between patients and physicians that are promoted by the Asthma 
Guidelines from the National Heart, Lung and Blood Institute (NHLBI). 
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Introduction 
The asthma guidelines issued by the National Heart Lung 
and Blood Institute (NHLBI) focus on four themes: 1. use 
of objective measures of lung function; 2. environmental 
controls; 3. comprehensive pharmacological therapy for 
both long-term control and management of exacerbations; 
and 4. patient education that fosters a partnership with 
clinicians (1). The section on drug therapy emphasizes 
the use of anti-inflammatory or ‘controller’ medications, 
particularly inhaled corticosteroids (ICS), for patients with 
persistent asthma. Poor patient compliance with controller 
medications would be expected to increase the hos- 
pitalization rate for asthmatic patients dramatically (2). 
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However, although nearly two-thirds of all medical visits for 
the management of asthma are to primary care physicians 
(3), little is known about primary-care patients’ understand- 
ing of and compliance with prescribed treatment regimens. 
We report data from a survey of 394 asthmatics 
who were prescribed ICS and treated by primary-care 
practitioners in the Philadelphia area. The survey explored 
relationships among patients’ demographics, attitudes 
toward and patterns of use of ICS and their health beliefs. 
Methods 
PRIMARY CARE PRACTICE NETWORK 
The TriState Primary Care Research Network is a network 
of family practice sites in the Philadelphia area. The 
network includes residency programs as well as private 
practices in the TriState (Southeastern Pennsylvania, 
Southern New Jersey and Northern Delaware) area. Six 
private solo and group practices (11 physicians) and six 
practices affiliated with residency programs (169 physicians) 
participated in this study. 
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PATIENT SELECTION 
Patients were eligible for inclusion in this study if they: 
were active patients in one of the participating practices 
(at least one office visit in the previous 2 years, 1 January 
1995 to 31 December 1996); 
were between the ages of 18 and 49 inclusive as of 
December 1996; 
had a billing diagnosis of asthma (ICD-9 493.x, NOS) 
(4); and 
had been prescribed ICS in the past 2 years by their 
physician. 
The participating sites used their office billing systems to 
generate a list of patients who met the first three inclusion 
criteria. The ambulatory medical records (‘paper charts’) 
for all these patients were reviewed by a research assistant 
to determine if ICS had been prescribed. The final list of 
eligible patients included only those patients for whom 
ICS were prescribed or continued according to the physi- 
cian note for any office visit between January 1995 and 
December 1996. 
SURVEY 
The survey contained sections for the respondents’ demo- 
graphics and general health, experience with asthma, fre- 
quency of use of and attitudes to ICS and health beliefs. 
Patients’ self-reported frequency of use of ICS was queried 
in four categories, from ‘never’ to ‘at least twice a day 
almost every day’. 
If their ICS use was other than at least twice a day almost 
every day, they were asked to indicate the reasons. Patients 
checked as many reasons as were applicable from a list of 
16, which included perceived ineffectiveness of ICS, incon- 
venience of multiple inhalers, and concerns about side- 
effects and costs (see Appendix for a list of the reasons 
used). The last section of the survey measured patients’ 
health beliefs. Key constructs in the health belief model (5) 
include motivation, perceived benefits of complying with a 
specific treatment recommendation, perceived seriousness 
of the condition and risks of treatment. Asthma, hyperten- 
sion and diabetes are three chronic conditions for which 
health beliefs have been studied (6-10). We used previously 
published scales (6,8,9,11) as sources for 15 of the health 
belief items. Four others were newly constructed for this 
investigation. Responses to each question used a five-point 
Likert scale of agreement. 
Before the survey was mailed, patients received a post- 
card announcing the study and requesting their cooper- 
ation. The subsequent mailing included the survey 
instrument, cover letter, return envelope and $5.00 incen- 
tive to complete the survey. A second mailing was sent to 
those patients who did not respond. 
ANALYSIS 
Items in the Health Belief section of the survey were scored 
so that a higher score indicated more agreement. The 
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principal components methods was used to extract the 
health belief factors (12). This method uses the correlation 
matrix of scores on the health belief items to form internally 
consistent clusters. Clusters are then rotated to obtain an 
interpretable pattern of factor loadings -the correlation of 
the factor and the item. We used the popular Varimax 
technique, where the number of rotated factors were those 
with eigenvalues greater than 1.0 (13). We inspected the 
factor loadings and assigned the items to factors with which 
they were most highly correlated, such that each item was 
assigned to only one factor. The names of the factors were 
derived from the sources of the health belief items and from 
the rotated factor pattern. All items and factors are listed in 
the Appendix. 
Stepwise logistic regression was used to model associ- 
ations between frequency of use of ICS and other factors. 
Frequency of use of ICS was dichotomized as ‘at least twice 
a day almost every day’ versus all other responses. Indepen- 
dent variables were gender (male/female), race (African- 
American/other), education (high school graduate or 
above/less than high school), living alone (yes/no), married 
(yes/no), ER admission for asthma in the past 12 months 
(yes/no), hospitalized for asthma in the past 12 months 
(yes/no), missed work or school for asthma in the past 12 
months (yes/no), self-reported health status (excellent or 
very good/good, fair or poor), and scores on the health 
belief scales. Scores on the health belief scales were 
categorized as either below the median or equal to or above 
the median score. All analyses were done using the PC 
version 6.11 of the Statistical Analysis System (SAS) at a 
Type I error rate of 0.05. 
INSTITUTIONAL APPROVAL 
The study procedures were approved by the appropriate 
Institutional Review Boards at the participating 
institutions. 
Results 
Of the 694 surveys mailed, 44 were not delivered because of 
address problems. Of the remaining 650 forms, 435 (67%) 
were returned. Forty-one of these were excluded from 
analysis because they were from patients who indicated they 
either did not have asthma or were not in the eligible age 
range. All data analysis was done on the remaining 394 
forms. 
DEMOGRAPHICS 
The demographics of the group are shown in Table 1. 
Eleven per cent rated their general health as excellent; 32% 
rated it very good, 34% good, 21% fair and 3% poor. 
MORBIDITY RELATED TO ASTHMA 
Nearly ha!f the patients had had at least one hospitalization 
for asthma in their life (Table 2). Fewer had been admitted 
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TABLE 1. Demographics of respondents (n=394) 
Median age (years) 
Gender (%) 
Female 
Male 
Race (%) 
African-American 
White 
Hispanic 
Asian 
Other 
Marital Status (%) 
Single, never married 
Married 
Divorced 
Other 
Educational level (%) 
Graduate school 
College graduate 
Some college 
High school graduate 
Other 
36 
75 
25 
51 
40 
4 
3 
3 
47 
39 
11 
3 
18 
20 
28 
22 
12 
to a hospital (14%) or treated in an emergency room (29%) 
in the previous year but 50% had missed work or school 
in that period. A majority of patients had experienced 
nocturnal symptoms and asthma attacks in the previous 
4 weeks: 86% of patients reported at least some breathing 
symptoms between asthma attacks. 
PATTERNS OF ICS USE 
Sixty-two per cent of patients reported less than regular, 
twice-daily use of ICS (Table 3). Only five reasons for 
inconsistent use were selected by more than 10% of these 
respondents (Table 4). The most common reason was ‘I use 
it only when I need it’. 
HEALTH BELIEFS 
Table 5 shows the psychometric statistics and a sample item 
for each Health Belief subscale. The item with the highest 
factor loading within the rotated factor pattern and the 
percentage agreement are shown. 
LOGISTIC REGRESSION ANALYSIS 
Using the stepwise procedure to model self-reported com- 
pliance with ICS, only three variables emerged as indepen- 
dent predictors: having been hospitalized for asthma in the 
past 12 months, and the ‘Serious’ and ‘Active’ health belief 
subscores. Table 6 shows the odds ratios and 95% CI for 
each of the three variables in the regression analysis. The 
Hosmer-Lemeshow goodness-of-fit test value was 8.5 
(df=5; P=O.13). 
TABLE 2. Self reported morbidity related to asthma (n=394) 
Ever hospitalized for asthma (%) 
In past 12 months (%) 
Treated in emergency room for asthma 
Hospitalized for asthma 
Missed work or school because of asthma 
Nocturnal symptoms in past 4 weeks (%) 
0 
1 night 
2-4 nights 
557 nights 
28 nights 
‘Asthma attacks’* in past 4 weeks 
0 
~1 per week 
1-2 week per 
23 week per 
Breathing between ‘asthma attacks’ 
No problems 
Symptoms some days 
Symptoms most days, inhaler required 
Symptoms most of the time 
45 
29 
14 
50 
37 
13 
32 
9 
9 
38 
30 
20 
12 
14 
48 
31 
7 
*Defined as a ‘sudden worsening of your asthma’. 
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TABLE 3. Percentage of respondents reporting use of steroid inhaler by option 
Option %* 
I use it at least twice a day almost every day 38 
Some days I use it at least twice, but on other days I don’t use it at all 36 
I used to use it, but now I don’t 22 
I never used it 4 
*Based on 386 respondents; eight patients left this item blank. 
TABLE 4. Five most frequently selected reasons for not using 
ICS (% of total selecting item) 
Reason % 
I use it only when I need it 62 
I don’t like using medicine unless I feel sick 33 
I don’t want to use steroids 21 
I feel fine 22 
I don’t like the side-effects 18 
Based on 247 respondents that did not report using ICS at 
least twice a day almost every day; respondents were 
allowed to select multiple items. 
Discussion 
Only 38% of the patients in our survey reported using ICS 
at least twice a day almost every day, the response category 
in our survey that most closely reflects the recommended 
level of use for patients with persistent asthma (1). Other 
studies also suggest that patient compliance with inhaled 
controller medications is poor in general (14-16) and sig- 
nificantly lower than compliance with oral theophylline 
(17). In light of the chronic inflammatory airway disease in 
asthma, understanding the inconsistent use or non-use of 
prescribed ICS presents a major clinical challenge. 
The reasons respondents selected most frequently for not 
using ICS almost every day suggest that many patients with 
asthma conceptualize the disease as periods of wellness 
interspersed with exacerbations of the disease, a model for 
which inconsistent use of chronic medication is not surpris- 
ing. Such a model is particularly troubling for the patients 
in this study, however, given their self-reported morbidity 
related to asthma. 
Patients hospitalized in the past 12 months for asthma or 
patients with the health belief that asthma was ‘Serious’ 
were 2.3 times more likely to use their medication every day 
than those who did not have these attributes, independent 
of other factors. The issue for physicians is how to convince 
patients that preventive therapy is needed without having to 
wait for the patient to experience a crisis (7). While 
hospitalization may represent a ‘teachable moment’ (18,19) 
for asthmatic patients, it is imprudent to focus medication 
compliance programs only on the subset of patients who 
have been hospitalized in a given year. 
Additional attention needs to be paid to the role of active 
decision-making on the part of patients in selecting the 
therapeutic approach for managing the disease. In our 
survey, patients reporting an ‘Active’ health belief exempli- 
fied by shared decisions about treatment had 4.5 times the 
likelihood of using their controller medication every day as 
those who did not have this health belief. The importance 
of informed decision-making and of a partnership between 
patients and providers in medical decision-making is 
increasingly being discussed in the medical literature (20- 
24). A recent study in which the process of primary care 
decision-making during office visits was audiotaped found 
that physicians frequently described the nature of their 
decisions, less frequently discussed the risks and benefits, 
and rarely assessed the patient’s understanding of the 
decision (25). Patient preferences were elicited in only 19% 
of the decisions. 
While the concept of partnership and shared decision- 
making is fundamental to the practice of primary care 
medicine, the primary care setting may be a difficult one in 
which to incorporate this approach to care. Because the 
agenda for most primary care visits is set by the patient, 
discussions about asthma-related issues may lose out to 
competing priorities. Although some have advocated refer- 
ral of selected asthmatic patients to specialists (26,27), the 
practical implications and acceptability of this strategy have 
not been assessed. 
Although the importance of shared decision-making in 
the management of asthma cannot be denied, our study 
does not show a causal relationship between an ‘Active’ 
health belief and compliance. It may be that both the 
attribute and the behaviour are the result of some other 
patient characteristic. In addition, it is not clear that all 
patients are interested in active decision-making. While 
patients who are more active decision-makers may force 
this model of care on their providers; it may be difficult for 
patients not inclined to this approach to be coached in how 
to be active decision-makers. 
The strength of the relationship that we observed 
between active decision-making by patients and compliance 
with ICS is limited by the self-reported data. Since the 
survey was mailed to the patients’ homes and responses 
were confidential, we believe there was less chance that 
patients would feel compelled to report compliance with 
their medication than if the questions had been asked in an 
office interview. Other methods such as weighing canisters 
(14) or counting prescription refills (15) would provide 
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TABLE 5. Health belief subscales, psychometric statistics and sample items 
Subscale Items Alpha* Loading? Item with highest loading O/$ 
Active 4 0.88 0.72 My physician and I decide together about treatment for my asthma 66 
Barriers 4 0.89 0.75 No matter what you do, if you are going to get sick, you will get sick 28 
Benefits 2 0.80 0.80 I believe it is possible to be completely free of asthma symptoms 42 
Frustration 3 0.89 0.79 I need more training in how to use my asthma medicine 14 
Motivation 3 0.95 0.82 I think about my health a lot 73 
Serious 3 0.90 0.71 My asthma is no problem as long as I feel all right 53 
Total 19 0.71 
*Estimates of Cronbach’s Alpha for a 19-item scale, using the Spearman-Brown equation. 
‘From rotated factor pattern: using Varimax method. 
$Percentage Agree or Strongly agree. 
TABLE 6. Patient factors associated with regular use of ICS 
(by logistic regression) 
Variable 
Odds 
ratio 
95% confidence 
interval 
‘Active’ health belief 4.6 2.8-7.5 
‘Serious’ health belief 2.3 143.7 
Hospitalization 2.3 1.64.6 
See text for description of model used. 
more objective measures of compliance; however, it would 
be difficult to match the health beliefs of individuals with 
these data in a population study. The cross-sectional design 
also limited our ability tbassess whether regular use of ICS 
was appropriate for all patients in this study. Although all 
respondents had a diagnosis of asthma, there was no 
evidence beyond a prescription for ICS that any patient’s 
disease severity met criteria for persistent asthma. Further- 
more, the instructions that physicians gave to their patients 
about how to take ICS were not available. It is possible that 
some of the patients had only intermittent asthma and 
were, in fact, instructed by their doctors to take medications 
sporadically. Even patients with mild, persistent asthma 
may not have been instructed to take their ICS medication 
daily since the need for this is challenged by some authori- 
ties (28,29). This uncertainty may also contribute to the 
inconsistent use of ICS reported by patients. Nonetheless, 
the associations we observed between compliance and 
patients’ health beliefs suggest that improvements in 
asthma care may be dependent upon better communication 
between patients and providers, and upon a more active 
role of patients in selecting the type of medication used to 
control asthma. 
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Appendix 
The health belief items to which the patients responded are shown below, by subscale: 
ACTIVE 
I feel better when I listen to my physician’s advice. 
I feel I will always need to take medicine to control my asthma. 
My physician and I decide together about my treatment for asthma. 
I am satisfied with the treatment I am currently receiving for my asthma. 
BARRIERS 
Good health is a matter of good luck. 
No matter what I do I cannot control my asthma. 
No matter what you do, if you are going to get sick, you will get sick. 
It is God’s will that I have asthma. 
BENEFITS 
Medicine can help but not cure asthma. 
I believe it is possible to be completely free of asthma symptoms. 
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FRUSTRATION 
I cannot understand everything I have been told about asthma. 
Taking medicine to control asthma interferes with my daily activities. 
I need more training in how to use my asthma medicine. 
MOTIVATION 
I think about my health a lot. 
Whenever I get sick, it concerns me a lot. 
My health is the most important consideration in my life. 
SERIOUS 
My asthma is no problem to me as long as I feel all right. 
My asthma will cause me to be sick a lot. 
It is very difficult for me to take care of my asthma. 
The item concerning reasons why patients might not use ICS as prescribed is reproduced below. 
If you do not use your steroid inhaler almost every day, can you tell us why? (choose as many as apply to you) 
0 I don’t need another inhaler. 
q It’s too complicated to use two or more inhalers. 
q I don’t want to use steroids. 
q It’s too difficult to carry two or more inhalers. 
[7 It doesn’t help me feel better. 
q It was inconvenient. 
0 I’m too lazy. 
q I don’t like the side-effects. 
0 It costs too much. 
0 It ran out and I never had it refilled. 
q I use it only when I need it. 
q I’m not sure which inhaler to use. 
0 I feel fine. 
q I don’t like using medicine unless I feel sick. 
0 I feel the same whether I use the inhaler or not. 
q It’s hard for me to use the inhaler. 
